In 2008, Nakamura et al demonstrated that TSP‐2 inhibits cell invasion by down‐regulating MMP‐9 and urokinase‐type plasminogen activator (μPA) activity in pancreatic cancer cell lines.47 Here, MMP9 is linked to pancreatic neoplasm.